Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PABPC1 | P11940 | 1/20 | 0.58 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.53 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.53 |
| ▸ | BACE1 | P56817 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | NQO2 | P16083 | 5/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.42 |
| ▸ | UBA2 | Q9UBT2 | 1/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.40 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30179258 | 1.00 | PABPC1 (0.58) | PABPC1PIK3R1PIK3CABACE1HTT | |
| SCHEMBL28634341 | 1.00 | PABPC1 (0.58) | PABPC1PIK3R1PIK3CABACE1HTT | |
| SCHEMBL16862275 | 0.92 | NQO2 (0.57) | PABPC1PIK3R1PIK3CABACE1HTT | |
| SCHEMBL30839234 | 0.92 | NQO2 (0.57) | PABPC1PIK3R1PIK3CABACE1HTT | |
| SCHEMBL30839235 | 0.92 | NQO2 (0.57) | PABPC1PIK3R1PIK3CABACE1HTT | |
| SCHEMBL28198392 | 0.89 | PABPC1 (0.54) | PABPC1PIK3R1PIK3CABACE1HTT | |
| SCHEMBL15196675 | 0.89 | PABPC1 (0.54) | PABPC1PIK3R1PIK3CABACE1HTT | |
| SCHEMBL24277660 | 0.86 | NQO2 (0.65) | PABPC1PIK3R1PIK3CABACE1HTT | |
| SCHEMBL10926535 | 0.85 | PABPC1 (0.50) | PABPC1PIK3R1PIK3CABACE1HTT | |
| SCHEMBL4143144 | 0.85 | PABPC1 (0.55) | PABPC1PIK3R1PIK3CABACE1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3696602-B1 | ELECTROCHROMIC ELEMENT, OPTICAL FILTER, LENS UNIT, IMAGING DEVICE, AND WINDOW MATERIAL | CANON KK (JP) | 2025-06-11 | — | — | EP | disclosed |
| EP-3696603-B1 | ELECTROCHROMIC ELEMENT, OPTICAL FILTER, LENS UNIT, IMAGING DEVICE, AND WINDOW MATERIAL | CANON KK (JP) | 2025-06-04 | — | — | EP | disclosed |
| US-12174404-B2 | Light-controlling device | CANON KABUSHIKI KAISHA (JP) | 2024-12-24 | — | — | US | disclosed |
| US-12081855-B2 | Light modulating element and optical apparatus, imaging apparatus and lens unit using the same | CANON KABUSHIKI KAISHA (JP) | 2024-09-03 | — | — | US | disclosed |
| US-12078905-B2 | Electrochromic element, optical filter, lens unit, image pickup apparatus, and window member | CANON KABUSHIKI KAISHA (JP) | 2024-09-03 | — | — | US | disclosed |
| CN-117820345-A | Blue light material based on dibenzofuran-aza condensed ring, preparation and application thereof | 山西大同大学 | 2024-04-05 | — | — | CN | disclosed |
| US-11661546-B2 | Electrochromic element, optical filter, lens unit, image pickup apparatus, and window member | CANON KABUSHIKI KAISHA (JP) | 2023-05-30 | — | — | US | disclosed |
| US-11661546-B2 | Electrochromic element, optical filter, lens unit, image pickup apparatus, and window member | CANON KABUSHIKI KAISHA (JP) | 2023-05-30 | — | — | US | disclosed |
| US-11661546-B2 | Electrochromic element, optical filter, lens unit, image pickup apparatus, and window member | CANON KABUSHIKI KAISHA (JP) | 2023-05-30 | — | — | US | disclosed |
| CN-113196114-B | Light control element | 佳能株式会社 | 2023-02-28 | — | — | CN | disclosed |
| US-20120040962-A1 | FUSED RING INHIBITORS OF HEPATITIS C | PRESIDIO PHARMACEUTICALS, INC. (US) | 2012-02-16 | — | — | US | disclosed |
| US-20120040962-A1 | FUSED RING INHIBITORS OF HEPATITIS C | PRESIDIO PHARMACEUTICALS, INC. (US) | 2012-02-16 | — | — | US | disclosed |
| US-20120040962-A1 | FUSED RING INHIBITORS OF HEPATITIS C | PRESIDIO PHARMACEUTICALS, INC. (US) | 2012-02-16 | — | — | US | disclosed |
| EP-2410843-A1 | FUSED RING INHIBITORS OF HEPATITIS C | Presidio Pharmaceuticals, Inc. (US) | 2012-02-01 | — | — | EP | disclosed |
| US-8101776-B2 | Organic semiconductors and their manufacture | BASF SE (DE) | 2012-01-24 | — | — | US | disclosed |
| US-8101776-B2 | Organic semiconductors and their manufacture | BASF SE (DE) | 2012-01-24 | — | — | US | disclosed |
| WO-2010111534-A1 | FUSED RING INHIBITORS OF HEPATITIS C | PRESIDIO PHARMACEUTICALS, INC. (US) | 2010-09-30 | — | — | WO | disclosed |
| US-20090299070-A1 | Organic Semiconductors and Their Manufacture | CLAP CO., LTD. (KR) | 2009-12-03 | — | — | US | disclosed |
| US-20090299070-A1 | Organic Semiconductors and Their Manufacture | CLAP CO., LTD. (KR) | 2009-12-03 | — | — | US | disclosed |
| WO-2007068618-A1 | ORGANIC SEMICONDUCTORS AND THEIR MANUFACTURE | CIBA HOLDING INC. (CH) | 2007-06-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090299070-A1 | Organic Semiconductors and Their Manufacture | YBX1, CDYL, PROX1 | PABPC1 3437/4885PIK3R1 2953/4885PIK3CA 1484/4885 |
| US-12078905-B2 | Electrochromic element, optical filter, lens unit, image pickup apparatus, and window member | HCN2, HCN4, HCN3 | PABPC1 3229/4885PIK3R1 1221/4885PIK3CA 1102/4885 |
| US-20120040962-A1 | FUSED RING INHIBITORS OF HEPATITIS C | HAVCR2, HCCS, ZC3HAV1 | PABPC1 937/4885PIK3R1 330/4885PIK3CA 927/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.